113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy
Noriko Iwamoto(Shimadzu (Japan)), Bernard A. Fox(Oregon Health & Science University), Tarsem Moudgil(Providence Portland Medical Center), R. Bryan Bell(Takara (United States)), Tanisha Christie(Providence Portland Medical Center), Rom S. Leidner(Providence Portland Medical Center), Alexa Dowell(Providence Portland Medical Center), Traci Hilton(UbiVac (United States)), Yoshinobu Koguchi(Providence Portland Medical Center), Brian Piening(Providence College), Takashi Shimada(Keio University), Eric Tran(Providence Portland Medical Center), Hong‐Ming Hu(Viva Biotech (China)), Ryan Meng(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center)
Cited by 1
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
|European Journal of Cancer|2017|565